e-learning
resources
London 2016
Tuesday, 06.09.2016
Preclinical pharmacology: drug targets and mechanisms of action
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma
Fernanda Paula Roncon Santana (Diadema, Brazil), Fernanda Paula Roncon Santana, Thaís Lourenço Ramos, Anna Carolina Morais Tavares, Nathália Montouro Pinheiros, Camila Pivari Pedroso Sadoka, Simone Dos Santos Grecco, Mariangela Macchione, Kelly Yoshizaki, Iolanda de Fátima Lopes Calvo Tibério, Milton de Arruda Martins, João Henrique Ghilardi Lago, Alessandra Choqueta Toledo, Carla Máximo Prado
Source:
International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Session:
Preclinical pharmacology: drug targets and mechanisms of action
Session type:
Thematic Poster
Number:
4089
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fernanda Paula Roncon Santana (Diadema, Brazil), Fernanda Paula Roncon Santana, Thaís Lourenço Ramos, Anna Carolina Morais Tavares, Nathália Montouro Pinheiros, Camila Pivari Pedroso Sadoka, Simone Dos Santos Grecco, Mariangela Macchione, Kelly Yoshizaki, Iolanda de Fátima Lopes Calvo Tibério, Milton de Arruda Martins, João Henrique Ghilardi Lago, Alessandra Choqueta Toledo, Carla Máximo Prado. Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma. Eur Respir J 2016; 48: Suppl. 60, 4089
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Potential effect of the extract of
zataria multiflora
and its consituent carvacrol on lung inflammation of sensitized guinea pigs
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Effects of rosemary and platanus extracts on asthmatic subjects resistant to traditional treatments
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Montelukast improves air trapping, not airway remodeling, in moderate-to-severe patients with asthma: A pilot tudy
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Azithromycin exhibits interferon-inducing properties in an experimental mouse model of asthma exacerbation
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
In-vitro bronchodilator activity clitoria ternatea and A. precatorius
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Study of antioxidant use in patients with asthma exacerbations
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Evaluation of bronchodilator activity of A. precatorius leaves
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Polyphenolic compounds and experimentally induced allergic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Rapamycin protects OVA induced asthma in mice through regulating autophagy
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Gender differences in patients with aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
The effect of oligomeric proanthocyanidin on airway microenvironment in asthma
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept